CClinicalTrials.gg
Not yet recruitingNCT07447947REVEUpdated Mar 4, 2026

Lived Experience and Perceptions of Menopause Among Patients Participating in the Multidisciplinary Care Pathways at Paris Saint-Joseph Hospital

An observational study in Menopause, sponsored by Fondation Hôpital Saint-Joseph. Not yet recruiting at 1 site in France. Open to female participants aged 45 Years to 60 Years. Per ClinicalTrials.gov, last updated 2026-03-04.

Sponsored by Fondation Hôpital Saint-Joseph · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
24
Ages
45 Years to 60 Years
Sex
Female
01

Study summary

Menopause, often reduced to its biological aspects, is increasingly studied through medical, psychological, social, and cultural lenses. Women's experiences vary widely depending on context-country, era, and social status. Their perceptions are ambivalent: while some associate menopause with the end of fertility and burdensome physical symptoms (hot flashes, joint pain, sleep disorders, mood swings, brain fog, vaginal dryness, low libido, weight gain), others see it as a liberating phase, free from reproductive expectations. Surprisingly, 87% of women report a positive experience of menopause itself, though the transitional phase is less well-tolerated (78%).

In France, where women's life expectancy is 87, they spend a third of their lives post-menopause. Yet, menopause remains a taboo subject. While 87% of women aged 50-65 experience at least one symptom beyond the cessation of menstruation, 25% suffer severe symptoms. The silence around menopause is striking: 48% of women under 50 find it difficult to discuss, 39% of pre-menopausal women feel anxious, 46% have never discussed it with their partner, and only 61% have consulted a healthcare professional. This silence stems from outdated sexist views, societal valorization of youth, lack of intergenerational dialogue, and insufficient targeted health policies, leading to isolation and invisibility.

Medical support often focuses on a biomedical model, particularly Hormone Replacement Therapy (HRT), which remains controversial since the 2002 WHI study. Only 2.5% of French women over 45 currently use HRT, and 45.4% view it negatively. However, women's experiences extend far beyond hormonal concerns.

To address these gaps, multidisciplinary programs-such as those at Paris Saint-Joseph Hospital and Toulouse University Hospital-offer group-based approaches, addressing physical, psychological, and relational dimensions. These programs provide a much-needed space for exchange, often absent in traditional care. Research on the benefits of collective discussion spaces (in-person or digital) in menopause care is limited, making it relevant to explore how these programs influence women's perceptions of menopause, their bodies, and their healthcare journey. While qualitative studies have examined individual experiences, few have focused on the dynamics of shared dialogue.

02

Conditions studied

  • Menopause
03

In context

Lead sponsor

Fondation Hôpital Saint-Joseph is the lead sponsor of 335 studies on the registry; 48 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
45 Years to 60 Years
Sexes eligible
Female
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Women participating in the multidisciplinary program offered at the Paris Saint Joseph Hospital and fulfilling the eligibility criteria

Inclusion criteria

  • Women
  • Between age 45 and age 60
  • French speaking
  • participating in the multidisciplinary program offered a the Paris Saint Joseph Hospital
  • Patient who does not object to the use of these data for research purposes

Exclusion criteria

Exclusion Criteria:

  • Patient under guardianship or conservatorship
  • Patient deprived of liberty (incarcerated or institutionalized)
  • Patient under judicial protection
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
24 participants (estimated)
Patient registry
No

Interventions

  • OtherFocus Group

    Women will participate in a focus group to discuss their Experiences and Perceptions of Menopause

06

What researchers measure

Primary outcomes

  1. Identify women's specific Experience and Perceptions of Menopause

    Time frame: 1 day

07

Study locations

1 site
  • Hôpital Paris Saint Joseph
    Paris, 75014, France
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 4, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07447947
Lead sponsor
Fondation Hôpital Saint-Joseph
Responsible party
Sponsor
First posted
Mar 4, 2026
Start date
May 2026 (estimated)
Primary completion
Nov 2026 (estimated)
Completion
Mar 2027 (estimated)
Last update
Mar 4, 2026

Study contacts

Juliette COURTIADE MAHLER, PhD
Contact
jcourtiade@ghpsj.fr
+33144127963
Akila LAZRI, MD
principal investigator · Fondation Hôpital Saint-Joseph

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Feb 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion